# 1999 International Union of Crystallography Printed in Denmark ± all rights reserved 3-Deoxy-d-arabino-heptulosonate-7-phosphate synthase (E.C. 4.1.2.15) catalyzes the ®rst step in the biosynthesis of aromatic amino acids: the condensation of phophoenolpyruvate and erythrose 4-phosphate to 3-deoxy-d-arabino-heptulosonate-7-phosphate. Diffraction-quality crystals of the tyrosine-inhibitable form of the enzyme from Saccharomyces cerevisiae have been obtained by the hanging-drop vapour-diffusion method in the presence of polyethylene glycol. The crystals belong to the triclinic space group P1, with unit-cell parameters a = 81.5, b = 94.0, c = 104.6 A Ê , = 65.5, = 85.2, = 75.0 , and can be¯ash-cooled using glycerol as a cryoprotectant. A data set to 2.3 A Ê has been collected at 120 K.
Introduction
Biosynthesis of the three aromatic amino acids in microorganisms and plants starts with the production of their common precursor chorismic acid as a result of the shikimate pathway. The ®rst reaction of this pathway, the condensation of erythrose-4-phosphate (E4P) and phosphoenolpyruvate (PEP) to 3-deoxy-darabino-heptulosonate-7-phosphate, is catalyzed by 3-deoxy-d-arabino-heptulosonate-7-phosphate synthase (DAHPS; E.C. 4.1.2.15).
The yeast Saccharomyces cervisiae contains two DAHPS isoenzymes whose activity is subject to a twofold regulation. Amino-acid starvation increases enzyme synthesis via the activator Gcn4p, which increases transcription of the corresponding genes (Ku È nzler et al., 1992) . At the enzyme-activity level, the ®nal products of the pathway, phenylalanine and tyrosine, speci®cally regulate the isoenzyme acitivities (Paravicini et al., 1989; Schnappauf et al., 1998) ; the DAHPS isoenzyme encoded by the ARO3 gene is regulated by phenylalanine and the ARO4-encoded isoenzyme is inhibited by tyrosine. A wide variety of differentially controlled isoenzyme species has been observed for DAHP synthases in other organisms (Byng et al., 1982; Byng & Jensen, 1983) . Other organisms, including Escherichia coli or Neurospora crassa, carry a third DAHPS which is inhibited by tryptophan (Hoffmann et al., 1972; Nimmo & Coggins, 1981a,b; Byng & Jensen, 1983) .
Crystallization of the phenylalanine-regulated DAHPS from the prokaryote E. coli has been reported recently (Shumilin et al., 1996) . Our investigation focuses on the tyrosineregulated DAHPS from the eukaryote S. cerevisiae. The primary sequence deduced from the ARO4 gene consists of 370 codons, leading to a calculated molecular weight of 39.7 kDa (Ku È nzler et al., 1992) . The enzyme requires a divalent metal cofactor for full activity. It is not known which metal is incorporated by S. cerevisiae in vivo, but after treatment with the chelating agent EDTA, addition of metal ions such as Co 2+ , Zn
2+
, Cu
and Fe 2+ restores activity to varying levels (Schnappauf et al., 1998) .
Here, we describe a modi®ed puri®cation protocol, crystallization and preliminary X-ray analysis for the tyrosine-inhibitable DAHPS from S. cerevisiae.
Experimental

Puri®cation
The tyrosine-inhibitable DAHPS was isolated from S. cervisiae strain RH1326 (Mat a, aro3-2, aro4-1, leu2-2, gcd2-1) using the multicopy plasmid pME1200 (2 mm, ARO4, LEU2) and puri®ed as described in Schnappauf et al. (1998) , with the following modi®cations. In order to keep the preparation metal-free after removal of the in vivo incorporated metal, 0.4 mM EDTA was added to all buffers during the chromatography puri®cation steps. At the end of the procedure in Schnappauf et al. (1998) , an additional anion-exchange chromatography step with 10 mM Tris buffer pH 9.0 was applied in order to remove the last traces of contaminant proteins and to shift the system from pH 7.6 to pH 9.0. At a pH value of 9.0, the enzyme is active and the protein solubility is signi®cantly increased (the calculated isoelectric point of DAHPS is 6.5). For a typical preparation, the resulting solution contained the protein at a concentration between 0.3 and 0.5 mg ml À1 as determined by the method of Bradford (1976) and was incubated with ZnCl 2 crystallization papers at ®ve times the enzyme concentration for 4 h at 277 K. After addition of PEP (to ®ve times the enzyme concentration), the solution was incubated again for 4 h at 277 K. After an additional dialyzation step overnight against 10 mM Tris pH 9.0 containing 1 mM DTT, the protein solution was concentrated to 18 mg ml À1 and stored at 203 K.
Crystallization
Initial crystallization trials employing the hanging-drop vapour-diffusion method were performed with 41 high-pH solutions from Hampton Crystal Screens I (Jancarik & Kim, 1991) and II (Cudney et al., 1994) 
Data collection and processing
A rectangular crystal of approximate dimensions 0.50 Â 0.20 Â 0.10 mm grown from 18% PEG 3000 buffered with 10 mM Tris±HCl pH 9.0 was selected and the crystallization drop solution was exchanged for a buffer containing 20% PEG 3000, 10 mM Tris±HCl pH 9.0 and 25% glycerol as a cryoprotectant. To reach the ®nal concentration of the cryoprotective agent, the mother liquor of the crystal was exchanged stepwise against solutions containing 5, 10, 15, 20 and 25% glycerol. The crystal was then picked up with a ®bre loop (Teng, 1990) and immediately¯ash-cooled in a stream of gaseous nitrogen at 120 AE 1 K from a homemade cryo-apparatus. A data set was collected on a Siemens HiStar multi-wire proportional counter using graphite-monochromated Cu K radiation from a Siemens M18X rotating-anode X-ray generator (®ne-focus ®lament, graphite monochromator, 0.5 mm collimator) operated at 50 kV, 90 mA. The data set was obtained using 3 and 9 scans of 0.25 with 5 min exposure time. To establish the diffraction limit, partially complete data to 2.3 A Ê were collected using a 30 min exposure time. Re¯ections were indexed using FRAMBO Version 3.003 (Bruker Analytical X-ray Systems) and integrated with SAINT Version 5.00 (Bruker Analytical X-ray Systems). A semi-empirical correction for absorption and crystal decay was applied. Symmetry-equivalent re¯ections intensities were merged using XPREP Version 6.00 (Bruker Analytical X-ray Systems).
Data analysis
Merged diffraction intensities were converted to structure-factor amplitudes using the program TRUNCATE (French & Wilson, 1978; Collaborative Computational Project, Number 4, 1994) . The self-rotation function for re¯ections between 10.0 and 2.8 A Ê was evaluated in steps of 2 , with minimum and maximum integration radii of 2.8 and 14.0 A Ê , respectively, using the program POLARFFN (Collaborative Computational Project, Number 4, 1994).
Results
Crystals of DAHPS have been grown using PEG 2000 monomethylether (Fluka), PEG 3000 (Fluka), PEG 6000 (Hampton Research) and PEG 8000 (Hampton Research) as the precipitant at concentrations between 13 and 18%(w/w). Crystals grow between pH 8.0 and 9.0, the best results being obtained in 10 mM Tris±HCl at pH 9.0. At room temperature, crystals grow to maximum dimensions 0.50 Â 0.20 Â 0.1 mm within 3 d. (Fig. 1) . These peaks correspond to three mutually perpendicular (all angles between the direction of maximum self-rotation overlap are 90.0 AE 0.4 ) twofold axes, indicating a 222 non-crystallographic symmetry.
Ful®lment of the 222 non-crystallographic symmetry requires the presence of at least four or a multiple of four molecules in the unit cell. The Matthews coef®cient V m (Matthews, 1968) for four molecules of DAHPS in the unit cell is 4.4 A Ê 3 Da À1 . This value corresponds to only 28% of the unit cell being occupied by protein atoms, making it more likely that the unit cell accomodates eight molecules, giving rise to a solvent content of 44%, which corresponds to a V m of 2.2 A Ê 3 Da À1 . So far, no structure with a homologous sequence which could be used for molecular replacement has been deposited in the Protein Data Bank. The active-site metal can be readily replaced, and crystallization of DAHPS in complex with different metals is under way. Given the high degree of noncrystallographic symmetry present in the crystals, relatively weak experimental phase information may suf®ce to solve the structure. This work is supported by grants to GB from the Deutsche Forschungsgemeinschaft, the Volkswagenstiftung and the Fonds der Chemischen Industrie.
